KMID : 0370220030470060444
|
|
Yakhak Hoeji 2003 Volume.47 No. 6 p.444 ~ p.459
|
|
HPLC Determination and Pharmacokinetic Profile of Ethosuximide in Korean Subjects
|
|
¹èÁ¤¿ì/Bae JW
±èÁöÈ«/¾ç»óÀÎ/±èÇö°æ/ÀåÃá°ï/ÇÑÇý¿ø/¹Ú¿µ¼/¼ÕÀǵ¿/Kim JH/Yang SI/Kim HK/Jang CG/Han HW/Park YS/Sohn UD
|
|
Abstract
|
|
|
Ethosuximide is an oral anticonvulsantic agent used in the first choice anti-absence seizure drug. The purpose of this study was to assess the pharmacokinetic profile of the e thosuximide in healthy Korean volunteers and to develop the efficient assay method of ethosuximide in human plasma. The pharmacokinetics of ethosuximide administered orally was evaluated after a dose of 500 mg. Ethosuximide was assayed from plasma by a specific HPLC method reading absorbance at 195 nm. AUC was 1222¡¾160 ¥ìg/ml¡¤hr, Cmax 14.21¡¾1.74 ¥ìg/ml, Tmax 1.06¡¾0.62 hr and half-life 77.83¡¾12.46 hr. The half-life in Korean was longer than, in Caucasian (53~56 hr).
|
|
KEYWORD
|
|
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|